HAL will be down for maintenance from Friday, June 10 at 4pm through Monday, June 13 at 9am. More information
Skip to Main content Skip to Navigation
Journal articles

Insulin is a potent myeloma cell growth factor through insulin/IGF-1 hybrid receptor activation.

Abstract : Insulin and insulin growth factor type 1 (IGF-1) and their receptors are closely related molecules, but both factors bind to the receptor of the other one with a weak affinity. No study has presently documented a role of insulin as a myeloma growth factor (MGF) for human multiple myeloma cells (MMCs), whereas many studies have concluded that IGF-1 is a major MGF. IGF-1 receptor (IGF-1R) is aberrantly expressed by MMCs in association with a poor prognosis. In this study we show that insulin receptor (INSR) is increased throughout normal plasma cell differentiation. INSR gene is also expressed by MMCs of 203/206 newly diagnosed patients. Insulin is an MGF as potent as IGF-1 at physiological concentrations and requires the presence of insulin/IGF-1 hybrid receptors, stimulating INSR(+)IGF-1R(+) MMCs, unlike INSR(+)IGF-1R(-) or INSR(-)IGF-1R(-) MMCs. Immunoprecipitation experiments indicate that INSR is linked with IGF-1R in MMCs and that insulin induces both IGF-1R and INSR phosphorylations and vice versa. In conclusion, we demonstrate for the first time that insulin is an MGF as potent as IGF-1 at physiological concentrations and its activity necessitates insulin/IGF-1 hybrid receptor activation. Further therapeutic strategies targeting the IGF/IGF-1R pathway have to take into account neutralizing the IGF-1R-mediated insulin MGF activity.
Document type :
Journal articles
Complete list of metadata

https://www.hal.inserm.fr/inserm-00528166
Contributor : Monique Frei Connect in order to contact the contributor
Submitted on : Saturday, March 19, 2011 - 3:11:30 PM
Last modification on : Tuesday, March 15, 2022 - 9:38:03 AM
Long-term archiving on: : Monday, June 20, 2011 - 2:16:57 AM

Files

inserm-00528166_edited.pdf
Files produced by the author(s)

Identifiers

Collections

Citation

Anne Catherine Sprynski, Dirk Hose, Alboukadel Kassambara, Laure Vincent, Michel Jourdan, et al.. Insulin is a potent myeloma cell growth factor through insulin/IGF-1 hybrid receptor activation.. Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2010, 24 (11), pp.1940-50. ⟨10.1038/leu.2010.192⟩. ⟨inserm-00528166⟩

Share

Metrics

Record views

94

Files downloads

412